RELENZA
Prescription medicines
RELENZA
Product information:
RELENZA product monograph
Health-care Professional Information:
November 3, 2009 - Notice to Hospitals - Health Canada Endorsed Important Safety Information on PrRELENZA (zanamivir) Dry Powder for Inhalation
Consumer Information:
“Please read the “Consumer Information” leaflet for RELENZA located on this website as it contains important safety information on RELENZA.”
Information
Trademarks are owned by or licensed to the GSK group of companies.